Exelixis Profile

Exelixis Patent Grants

Process for making compounds for use in the treatment of cancer

Patent Number 10239858 - March 26, 2019

Disclosed herein is a process of making a compound of formula I The compound of formula I is an inhibitor of MEK and thus can be used to…

Method for treating osteoporosis

Patent Number 10166225 - January 1, 2019

This invention is directed to the treatment of osteoporosis using…

Dosing of cabozantinib formulations

Patent Number 10159666 - December 25, 2018

The invention relates to administration of various pharmaceutical formulations of…

Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds

Patent Number 10123999 - November 13, 2018

The present invention is directed to processes for making and compositions containing quinolines such as formula I or pharmaceutically…

Inhibitors of PI3K-delta and methods of their use and manufacture

Patent Number 10053470 - August 21, 2018

The invention is directed to Compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof as well as methods of making…

Exelixis Patent Applications

Drug Combination to Treat Melanoma

Application Number 20170224670 - August 10, 2017

This invention relates to the combination of vemurafenib and the heat shock protein 90 (HSP90) inhibitor XL888 to treat melanoma, particularly…

Inhibitors of PI3K-Delta and Methods of Their Use and Manufacture

Application Number 20170226131 - August 10, 2017

The invention is directed to Compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof as well as methods of making…

Crystalline Solid Forms of N--N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, Processes for Making, and Methods of Use

Application Number 20170044106 - February 16, 2017

The invention relates to novel crystalline solid forms of the chemical compound…

LXR MODULATORS

Application Number 20160304499 - October 20, 2016

The present invention provides compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof, as modulators of liver X…

LXR MODULATORS

Application Number 20160289222 - October 6, 2016

The present invention provides compounds of Formula I and Formula II: or pharmaceutically acceptable salts or solvates thereof, as modulators…

Exelixis Federal Litigation Filings

EXELIXIS, INC. v. CAMDEN PARTNERS HOLDINGS, LLC et al

California Northern District Court - March 3, 2017

Exelixis, Inc. v. Kappos

Virginia Eastern District Court - November 9, 2012

Exelixis, Inc. v. Honorable David J. Kappos There are opinions or orders for this case

Virginia Eastern District Court - May 29, 2012

Exelixis, Inc. v. Kappos There are opinions or orders for this case

Virginia Eastern District Court - January 27, 2012

Exelixis Federal District Court Decisions

Exelixis, Inc. v. Honorable David J. Kappos

Virginia Eastern District Court - January 28, 2013

MEMORANDUM OPINION in re 16 Motion for Summary Judgment and 13 Motion for Summary Judgment. Signed by District Judge Leonie M. Brinkema…